Clinical trial
PK/PD Study of Antibiotics in Critically Ill Patients Receiving ECMO
NCT06319677 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PK/PD Study of Antibiotics in Critically Ill Patients Receiving ECMO
- Lead sponsor
- The Third Xiangya Hospital of Central South University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2024
- Completion date
- May 1, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, extracorporeal membrane oxygenation complication